Literature DB >> 21070347

Children with atopic dermatitis appear less likely to be infected with community acquired methicillin-resistant Staphylococcus aureus: the San Diego experience.

Catalina Matiz1, Wynnis L Tom, Lawrence F Eichenfield, Alice Pong, Sheila Fallon Friedlander.   

Abstract

Given the increasing rate of community-acquired methicillin resistant Staphylococcus aureus skin infections in the population, such infections might be concurrently increasing in patients with atopic dermatitis. This study assessed current and prior rates of community-acquired methicillin resistant Staphylococcus aureus and methicillin-susceptible Staphylococcus aureus skin and soft tissue infections in children with atopic dermatitis compared to the general pediatric population. Other antibiotic sensitivity and resistance patterns, including clindamycin-inducible resistance, were also identified. Retrospective study of all skin and soft tissue isolates were positive for Staphylococcus aureus during two distinct 1-year periods, obtained by the outpatient services and the emergency department at Rady Children's Hospital, the major regional pediatric health center in San Diego, California. Of the Staphylococcus aureus isolates obtained from January to December 2000, none from atopic dermatitis patients were methicillin resistant Staphylococcus aureus, while 4.2% of those obtained from the general outpatient pediatric population showed methicillin resistance. In the period from June 2007 to May 2008, 11 of 78 isolates (14.1%) from children with atopic dermatitis were methicillin resistant Staphylococcus aureus. This was significantly lower than the rate of increase noted in the general pediatric population (658 of 1482, or 44.4%, in 2007/2008, p < 0.05). Clindamycin-inducible resistance was noted in 1.9% of the isolates in the general population; all six tested isolates from atopic patients lacked clindamycin-inducible resistance. In this study, children with atopic dermatitis had a much lower rate of community-acquired methicillin resistant Staphylococcus aureus infection compared to the general outpatient pediatric population. Clindamycin-inducible resistance was very low in both groups.
© 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21070347     DOI: 10.1111/j.1525-1470.2010.01293.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  11 in total

1.  Comorbidity in Atopic Dermatitis.

Authors:  Eric L Simpson
Journal:  Curr Dermatol Rep       Date:  2012-03-01

2.  High prevalence of mupirocin resistance in Staphylococcus aureus isolates from a pediatric population.

Authors:  Nina K Antonov; Maria C Garzon; Kimberly D Morel; Susan Whittier; Paul J Planet; Christine T Lauren
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

3.  Treatment outcomes of secondarily impetiginized pediatric atopic dermatitis lesions and the role of oral antibiotics.

Authors:  Jeffrey B Travers; Amal Kozman; Yongxue Yao; Wenyu Ming; Weiguo Yao; Mathew J Turner; Mark H Kaplan; Nico Mousdicas; Anita N Haggstrom; Chandan Saha
Journal:  Pediatr Dermatol       Date:  2011-12-09       Impact factor: 1.588

4.  Delayed acyclovir and outcomes of children hospitalized with eczema herpeticum.

Authors:  Paul L Aronson; Albert C Yan; Manoj K Mittal; Zeinab Mohamad; Samir S Shah
Journal:  Pediatrics       Date:  2011-11-14       Impact factor: 7.124

Review 5.  Diagnosis of Atopic Dermatitis: Mimics, Overlaps, and Complications.

Authors:  Elaine C Siegfried; Adelaide A Hebert
Journal:  J Clin Med       Date:  2015-05-06       Impact factor: 4.241

6.  Change in Antimicrobial Susceptibility of Skin-Colonizing Staphylococcus aureus in Korean Patients with Atopic Dermatitis during Ten-Year Period.

Authors:  Jung-Min Park; Ju-Hyun Jo; Hyunju Jin; Hyun-Chang Ko; Moon-Bum Kim; Jung-Min Kim; Do-Won Kim; Ho-Sun Jang; Byung-Soo Kim
Journal:  Ann Dermatol       Date:  2016-07-26       Impact factor: 1.444

7.  Decolonization of Staphylococcus aureus in patients with atopic dermatitis: a reason for increasing resistance to antibiotics?

Authors:  Izabela Błażewicz; Maciej Jaśkiewicz; Marta Bauer; Lidia Piechowicz; Roman J Nowicki; Wojciech Kamysz; Wioletta Barańska-Rybak
Journal:  Postepy Dermatol Alergol       Date:  2017-12-31       Impact factor: 1.837

8.  Risk of Skin and Soft Tissue Infections among Children Found to be Staphylococcus aureus MRSA USA300 Carriers.

Authors:  Lilly Cheng Immergluck; Shabnam Jain; Susan M Ray; Robert Mayberry; Sarah Satola; Trisha Chan Parker; Keming Yuan; Anaam Mohammed; Robert C Jerris
Journal:  West J Emerg Med       Date:  2017-01-27

9.  Novel sodium hypochlorite cleanser shows clinical response and excellent acceptability in the treatment of atopic dermatitis.

Authors:  Caitriona Ryan; Richard E Shaw; Clay J Cockerell; Shari Hand; Fred E Ghali
Journal:  Pediatr Dermatol       Date:  2013 May-Jun       Impact factor: 1.588

Review 10.  The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group.

Authors:  H Alexander; A S Paller; C Traidl-Hoffmann; L A Beck; A De Benedetto; S Dhar; G Girolomoni; A D Irvine; P Spuls; J Su; J P Thyssen; C Vestergaard; T Werfel; A Wollenberg; M Deleuran; C Flohr
Journal:  Br J Dermatol       Date:  2019-12-04       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.